Back to Funds

MRNYYieldMaxOption-Income

as of Oct 26, 2026

Holdings
7
Options
8
AUM
$223M
Total Wt
67.4%
Net Flow 7d
+3.8%
Option ActivityWed, Oct 14 – Mon, Oct 26

18 spreads Β· 3 expired Β· 3 synthetics Β· 2 rolls

Mon, Oct 26vs Fri, Oct 235 trades
SpreadMRNA
10/30/26 210/222.5 call spread Β· credit Β· resized
210C 10/30/26 -7,625 (-2,450 β†’ -10,075)222.5C 10/30/26 +7,625 (2,450 β†’ 10,075)
SpreadMRNA
10/30/26 215/227.5 call spread Β· credit Β· opened
215C 10/30/26 -1,000 (0 β†’ -1,000)227.5C 10/30/26 +1,000 (0 β†’ 1,000)
SpreadMRNA
10/30/26 212.5/225 call spread Β· credit Β· opened
212.5C 10/30/26 -575 (0 β†’ -575)225C 10/30/26 +575 (0 β†’ 575)
SpreadMRNA
10/23/26 220/232.5 call spread Β· credit Β· closed
220C 10/23/26 +300 (-300 β†’ 0)232.5C 10/23/26 -300 (300 β†’ 0)
SpreadMRNA
10/23/26 222.5/245 call spread Β· credit Β· closed
222.5C 10/23/26 +275 (-275 β†’ 0)245C 10/23/26 -275 (275 β†’ 0)
Fri, Oct 23vs Thu, Oct 227 trades
SpreadMRNA
10/23/26 222.5/235 call spread Β· credit Β· resized
222.5C 10/23/26 +4,600 (-4,875 β†’ -275)235C 10/23/26 -4,600 (4,600 β†’ 0)
ExpiredMRNA
252.5C 10/23/26 Β· long
252.5C 10/23/26 -3,200 (3,200 β†’ 0)
ExpiredMRNA
240C 10/23/26 Β· written
240C 10/23/26 +2,950 (-2,950 β†’ 0)
SpreadMRNA
10/30/26 210/222.5 call spread Β· credit Β· opened
210C 10/30/26 -2,450 (0 β†’ -2,450)222.5C 10/30/26 +2,450 (0 β†’ 2,450)
SpreadMRNA
10/23/26 250/262.5 call spread Β· credit Β· closed
250C 10/23/26 +2,000 (-2,000 β†’ 0)262.5C 10/23/26 -2,000 (2,000 β†’ 0)
SyntheticMRNA
11/20/26 135.01 synthetic long (stock exposure) Β· resized
135.01C 11/20/26 +750 (10,900 β†’ 11,650)FLEX135.01P 11/20/26 -750 (-10,900 β†’ -11,650)FLEX
ExpiredMRNA
230C 10/23/26 Β· written
230C 10/23/26 +250 (-250 β†’ 0)
Thu, Oct 22vs Wed, Oct 21no option trades
Show 5 earlier days
Wed, Oct 21vs Tue, Oct 202 trades
SpreadMRNA
10/23/26 220/232.5 call spread Β· credit Β· resized
220C 10/23/26 +900 (-1,200 β†’ -300)232.5C 10/23/26 -900 (1,200 β†’ 300)
SyntheticMRNA
11/20/26 135.01 synthetic long (stock exposure) Β· resized
135.01C 11/20/26 -900 (11,800 β†’ 10,900)FLEX135.01P 11/20/26 +900 (-11,800 β†’ -10,900)FLEX
Tue, Oct 20vs Mon, Oct 192 trades
SpreadMRNA
10/23/26 230/240 call spread Β· credit Β· resized
230C 10/23/26 -250 (0 β†’ -250)240C 10/23/26 +250 (-3,200 β†’ -2,950)
SyntheticMRNA
11/20/26 135.01 synthetic long (stock exposure) Β· resized
135.01C 11/20/26 +250 (11,550 β†’ 11,800)FLEX135.01P 11/20/26 -250 (-11,550 β†’ -11,800)FLEX
Mon, Oct 19vs Fri, Oct 168 trades
SpreadMRNA
10/23/26 222.5/235 call spread Β· credit Β· resized
222.5C 10/23/26 -4,875 (0 β†’ -4,875)235C 10/23/26 +4,875 (-275 β†’ 4,600)
SpreadMRNA
10/16/26 217.5/227.5 call spread Β· credit Β· closed
217.5C 10/16/26 +4,700 (-4,700 β†’ 0)227.5C 10/16/26 -4,700 (4,700 β†’ 0)
RollMRNA
235C 10/16/26252.5C 10/23/26Β· long
235C 10/16/26 -3,200 (3,200 β†’ 0)252.5C 10/23/26 +3,200 (0 β†’ 3,200)
RollMRNA
225C 10/16/26240C 10/23/26Β· written
225C 10/16/26 +3,200 (-3,200 β†’ 0)240C 10/23/26 -3,200 (0 β†’ -3,200)
SpreadMRNA
10/16/26 212.5/222.5 call spread Β· credit Β· closed
212.5C 10/16/26 +3,375 (-3,375 β†’ 0)222.5C 10/16/26 -3,375 (3,375 β†’ 0)
SpreadMRNA
10/23/26 220/232.5 call spread Β· credit Β· opened
220C 10/23/26 -1,200 (0 β†’ -1,200)232.5C 10/23/26 +1,200 (0 β†’ 1,200)
SpreadMRNA
10/16/26 200/210 call spread Β· credit Β· closed
200C 10/16/26 +225 (-225 β†’ 0)210C 10/16/26 -225 (225 β†’ 0)
SpreadMRNA
10/16/26 197.5/207.5 call spread Β· credit Β· closed
197.5C 10/16/26 +50 (-50 β†’ 0)207.5C 10/16/26 -50 (50 β†’ 0)
Fri, Oct 16vs Thu, Oct 152 trades
SpreadMRNA
10/23/26 250/262.5 call spread Β· credit Β· opened
250C 10/23/26 -2,000 (0 β†’ -2,000)262.5C 10/23/26 +2,000 (0 β†’ 2,000)
SpreadMRNA
10/23/26 235/245 call spread Β· credit Β· opened
235C 10/23/26 -275 (0 β†’ -275)245C 10/23/26 +275 (0 β†’ 275)
Thu, Oct 15vs Wed, Oct 14no option trades

Built from contract counts, not weights β€” a price move can't show up as a trade. Changes of equal size on the same stock are paired: a roll closes one expiry and opens the next, a synthetic (long call + written put at one strike) is stock exposure, not two bets. Negative = written.

Strategy Effectiveness
Analyzing option strategy effectiveness…